0001209191-22-051160.txt : 20220923
0001209191-22-051160.hdr.sgml : 20220923
20220923170620
ACCESSION NUMBER: 0001209191-22-051160
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220923
DATE AS OF CHANGE: 20220923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FAIRBAIRN EMILY
CENTRAL INDEX KEY: 0001682638
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 221262940
MAIL ADDRESS:
STREET 1: 10 ORINDA VIEW ROAD
CITY: ORINDA
STATE: CA
ZIP: 94563
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-06-01
2022-06-14
0
0001740279
IN8BIO, INC.
INAB
0001682638
FAIRBAIRN EMILY
10 ORINDA VIEW ROAD
ORINDA
CA
94563
1
0
1
0
Stock Option (right to buy)
2.24
2022-06-01
4
A
0
13500
0.00
A
2032-06-01
Common Stock
13500
13500
D
The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person.
One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2022-09-23